Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Valhi
VHI
$460M
| $2.26M | ﹤0.01% |
131,717
-3,000
| -2% | -$43.1K |
|
|
WSR
1952
DELISTED
Whitestone REIT
WSR
| $2.26M | ﹤0.01% |
180,084
-72,294
| -29% | -$893K |
|
1953
AnaptysBio
ANAB
$1.71B
| $2.26M | ﹤0.01% |
100,200
+4,600
| +5% | +$109K |
|
1954
Emergent Biosolutions
EBS
$237M
| $2.25M | ﹤0.01% |
891,300
+344,000
| +63% | +$775K |
|
|
TDAY
1955
USA Today Co
TDAY
$1.04B
| $2.25M | ﹤0.01% |
923,500
-330,324
| -26% | -$742K |
|
1956
Curtiss-Wright
CW
$25.8B
| $2.25M | ﹤0.01% |
8,800
+900
| +11% | +$209K |
|
|
PHLT
1957
DELISTED
Performant Healthcare Inc
PHLT
| $2.25M | ﹤0.01% |
764,163
+1,800
| +0.2% | +$5.14K |
|
|
SLN
1958
Silence Therapeutics
SLN
$645M
| $2.24M | ﹤0.01% |
103,900
+76,798
| +283% | +$1.67M |
|
1959
Pacer Trendpilot US Large Cap ETF
PTLC
$3.38B
| $2.24M | ﹤0.01% |
47,000
+24,595
| +110% | +$1.12M |
|
1960
Xeris Biopharma Holdings
XERS
$1.56B
| $2.23M | ﹤0.01% |
1,009,340
-372,300
| -27% | -$963K |
|
1961
United Fire Group
UFCS
$1.39B
| $2.23M | ﹤0.01% |
102,338
+72,055
| +238% | +$1.6M |
|
1962
iShares MSCI Europe Financials ETF
EUFN
$4.31B
| $2.23M | ﹤0.01% |
97,900
-84,900
| -46% | -$1.79M |
|
1963
NeoGenomics
NEO
$2.04B
| $2.23M | ﹤0.01% |
141,600
+41,800
| +42% | +$645K |
|
1964
4D Molecular Therapeutics
FDMT
$612M
| $2.23M | ﹤0.01% |
+69,833
| New | +$1.78M |
|
1965
Astronics
ATRO
$4.58B
| $2.22M | ﹤0.01% |
140,040
-77,701
| -36% | -$1.16M |
|
1966
Capital Group Growth ETF
CGGR
$25.1B
| $2.22M | ﹤0.01% |
69,400
-43,900
| -39% | -$1.32M |
|
|
CTV
1967
DELISTED
Innovid Corp.
CTV
| $2.22M | ﹤0.01% |
891,481
+104,400
| +13% | +$181K |
|
1968
Invesco Total Return Bond ETF
GTO
$2.47B
| $2.21M | ﹤0.01% |
47,300
+28,938
| +158% | +$1.35M |
|
1969
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
| $2.21M | ﹤0.01% |
53,607
-16,093
| -23% | -$663K |
|
1970
Radcom
RDCM
$171M
| $2.21M | ﹤0.01% |
197,733
+41,700
| +27% | +$407K |
|
1971
First Trust Rising Dividend Achievers ETF
RDVY
$25.7B
| $2.2M | ﹤0.01% |
39,200
+12,600
| +47% | +$661K |
|
|
ADAP
1972
DELISTED
Adaptimmune Therapeutics
ADAP
| $2.2M | ﹤0.01% |
1,391,775
+21,536
| +2% | +$26K |
|
1973
iShares MSCI France ETF
EWQ
$332M
| $2.19M | ﹤0.01% |
53,000
-45,700
| -46% | -$1.81M |
|
1974
Grupo Cibest SA
CIB
$22.8B
| $2.19M | ﹤0.01% |
64,100
-37,700
| -37% | -$1.22M |
|
1975
TAT Technologies
TATT
$532M
| $2.19M | ﹤0.01% |
181,202
-1,400
| -0.8% | -$16.9K |
|
Similar funds
Jim Simons's Q1 2024 Portfolio in Review
As of Q1 2024, Jim Simons held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Chevron worth $331M.
- Jim Simons's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Jim Simons added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Jim Simons's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Jim Simons fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Jim Simons's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Jim Simons opened 562 new positions and closed 582 in Q1 2024.
- Jim Simons's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.